Effect of Hyaluronic Acid/Trehalose in Two Different Formulations on Signs and Symptoms in Patients with Moderate to Severe Dry Eye Disease

scientific article published on 01 August 2018

Effect of Hyaluronic Acid/Trehalose in Two Different Formulations on Signs and Symptoms in Patients with Moderate to Severe Dry Eye Disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1155/2018/4691417
P932PMC publication ID6093073
P698PubMed publication ID30155282

P50authorAhmed M BataQ59665551
Gerhard GarhöferQ88489981
Katarzyna J WitkowskaQ90478627
Klemens FondiQ91189773
Leopold SchmettererQ42104184
Doreen SchmidlQ42641201
P2093author name stringAlina Popa-Cherecheanu
Piotr A Wozniak
P2860cites workOcular surface residence times of artificial tear solutionsQ67574579
[Osmoprotection as a new therapeutic principle]Q79926756
Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007)Q80347912
The association of sleep quality with dry eye disease: the Osaka studyQ28601496
Impact of dry eye syndrome on vision-related quality of life in a non-clinic-based general populationQ31072475
Ocular contact time of a carbomer gel (GelTears) in humansQ35302344
Sleep and mood disorders in dry eye disease and allied irritating ocular diseases.Q36634380
Pharmacological management of dry eye in the elderly patientQ37079081
Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meetingQ38151227
TFOS DEWS II Clinical Trial Design ReportQ38652975
TFOS DEWS II Epidemiology ReportQ38652994
TFOS DEWS II Management and Therapy ReportQ39453364
Precorneal residence time of artificial tears measured in dry eye subjectsQ40063368
Time course of changes in tear meniscus radius and blink rate after instillation of artificial tears.Q40217756
Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes.Q40948258
Tear film thickness after treatment with artificial tears in patients with moderate dry eye diseaseQ41479666
Corneal-protective effects of an artificial tear containing sodium hyaluronate and castor oil on a porcine short-term dry eye modelQ42459799
Association between clinical diagnostic tests and health-related quality of life surveys in patients with dry eye syndromeQ42940964
Effect of castor oil emulsion eyedrops on tear film composition and stabilityQ43229070
Carbomer and sodium hyaluronate eyedrops for moderate dry eye treatment.Q46447842
Effect of viscosity on tear drainage and ocular residence timeQ47417849
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjectalpha,alpha-trehaloseQ421773
eye diseaseQ3041498
P304page(s)4691417
P577publication date2018-08-01
P1433published inJournal of OphthalmologyQ26842872
P1476titleEffect of Hyaluronic Acid/Trehalose in Two Different Formulations on Signs and Symptoms in Patients with Moderate to Severe Dry Eye Disease
P478volume2018

Search more.